Phase Ia Pharmacokinetic and Tolerability Study of Oral NV-27 in Normal Healthy Volunteers
Latest Information Update: 16 Jul 2019
At a glance
- Drugs NV 27 (Primary)
- Indications Coronary artery restenosis
- Focus Pharmacokinetics
- Sponsors Kazia Therapeutics; Novogen
Most Recent Events
- 17 Nov 2017 According to a Kazia Therapeutics media release, Novogen changed its name to Kazia Therapeutics.
- 14 May 2009 New trial record